医学
表皮生长因子受体
肺癌
肿瘤科
双特异性抗体
癌症研究
内科学
抗体
癌症
皮肤病科
免疫学
单克隆抗体
作者
Shahnaz Singh-Kandah,Kaiwen Wang,Karen Xia,Andy Lain Johnson,Denise D’Andrea,Catherine A. Shu,Lindsay Dougherty,Stephanie M. Gallitano
标识
DOI：10.1188/24.cjon.1-8.ap
摘要
Amivantamab is an epidermal growth factor receptor (EGFR) and MET bispecific antibody approved for certain patients with advanced non-small cell lung cancer with EGFR variant. Cutaneous toxicities are known on-target effects of EGFR inhibition.
科研通智能强力驱动
Strongly Powered by AbleSci AI
杳鸢
不配.
嗯哼
乐乐乐乐乐乐
Endlessway
完美的天空
8R60d8
36456657
一一
xjcy
甜甜玫瑰
YuanbinMao
tuanheqi
精明的迎松
shinysparrow
Billy
pluto
HEIKU
pcr163
库昊的假粉丝
皖公网安备34019202002308
